HomeLuViVaPipelinePublicationsInvestorsNewsContactE-mail

News Releases

Board of Directors

Audit Committee Charter

Compensation Committee Charter

Key People

Regulatory Filings

Stock Quote

 
  Key People at Guided Therapeutics
  Mark L. Faupel, Ph.D., President, Chief Executive Officer and Director.

Dr. Faupel has more than 25 years of experience as a senior executive developing non-invasive alternatives to surgical biopsies and blood tests, especially in the area of cancer screening and diagnostics. Prior to coming to SpectRx in 1998 as Vice President of Business Development and then co-founding Guided Therapeutics, Dr. Faupel was a senior executive and co-founder of Biofield Corp. In 2007, he became President and CEO of Guided Therapeutics.

He is the inventor on 20 U.S. patents and author of numerous scientific publications and presentations, appearing in such peer-reviewed journals as The Lancet, Cancer, The European Journal of Radiology and Diabetes Technology & Therapeutics. He has served as a member of the European School of Oncology Task Force and on National Institutes of Health review panels.  Dr. Faupel earned his Ph.D. in neuroanatomy and physiology from the University of Georgia.


  Richard L. Fowler, Sr. Vice-president, Engineering.

Mr. Fowler is responsible for identifying new technical and business opportunities for Guided Therapeutics. These opportunities include new technologies, product lines or business acquisitions that are strategic to the Company's business. Mr. Fowler was formerly VP of Engineering at Guided Therapeutics where he oversaw the successful development of the BiliChek® Non-invasive Bilirubin Analyzer.

Mr. Fowler has more than 20 years experience in developing and bringing to market electro-optical devices. Prior to joining Guided Therapeutics, Mr. Fowler was President of Laser Atlanta Optics, Inc. where he developed and launched a new, low-cost laser range finder. He has also held management positions with GEC Avionics, Inc. and General Dynamics. Mr. Fowler holds a degree in Electrical Engineering from the University of Texas.

  Shabbir Bambot, Ph.D. Vice President, Research and Development.

Dr. Bambot is a co-founder of Guided Therapeutics. He has 20 years of experience in developing medical diagnostic products and is co-inventor of the technology behind the company’s cancer diagnostic products. At present he manages the development of the company’s esophageal cancer surveillance product in partnership with Konica Minolta Opto, Japan.

He has been instrumental in the successful launch of two point-of-care medical diagnostic products, the AVL/Roche OPTI 2® blood chemistry analyzer and the Guided Therapeutics BiliChek® Non-invasive Bilirubin Analyzer. Dr. Bambot has 8 patents, several publications and presentations in the areas of clinical monitoring and diagnostics and is the recipient of multiple NIH SBIR grants totaling in excess of $6.0 million for developing non-invasive diagnostic devices. He has experience with regulatory strategy and FDA 510K & PMA applications, quality systems compliance, clinical studies and regulations for conducting research on human subjects.


©2012 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service